World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
35437
World Ranking
7710
National Ranking
4009

Overview

Philip H. Gutin is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on medicine with specific emphasis on genetics, radiology, nuclear medicine and imaging, immunology, neurology, and pulmonary and respiratory medicine.

Their main topics of work include glioma diagnosis and treatment, radiopharmaceutical chemistry and applications, immune cells in cancer, neuroinflammation and neurodegeneration mechanisms, medical imaging techniques and applications, and prostate cancer treatment and research.

Philip H. Gutin has contributed to several scientific publications. Notable recent papers are:

  • Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells, 2020, published in Cell
  • [89Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma, 2021, published in European Journal of Nuclear Medicine and Molecular Imaging
  • Correction to: [89Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma, 2022, published in European Journal of Nuclear Medicine and Molecular Imaging

Frequent collaborators with Philip H. Gutin include Simone Krebs, Christian Grommes, Michael R. McDevitt, Sean Carlin, and Joseph A. O'Donoghue. Each of these coauthors has collaborated on multiple publications with Gutin.

Philip H. Gutin's work has been featured mainly in the following publication venues:

  • European Journal of Nuclear Medicine and Molecular Imaging
  • Cell

Best Publications

  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

    Robert M Samstein;Chung-Han Lee;Chung-Han Lee;Alexander N Shoushtari;Alexander N Shoushtari;Matthew D Hellmann;Matthew D Hellmann

  • NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

    Roger Stupp;Eric T. Wong;Andrew A. Kanner;David Steinberg

  • Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO

    Victoria E. Clark;E. Zeynep Erson-Omay;Akdes Serin;Jun Yin

  • Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells

    Florian Klemm;Florian Klemm;Roeltje R. Maas;Robert L. Bowman;Mara Kornete;Mara Kornete

  • Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.

    Penny K. Sneed;Paul R. Stauffer;Michael W. McDermott;Chris J. Diederich

  • Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

    Penny K Sneed;Kathleen R Lamborn;Julie M Forstner;Michael W McDermott

  • Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies

    Robert L. Bowman;Florian Klemm;Florian Klemm;Florian Klemm;Leila Akkari;Leila Akkari;Leila Akkari;Stephanie M. Pyonteck

  • Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.

    Victor A. Levin;Pamela Silver;John Hannigan;William M. Wara

  • Intergeneric poliovirus recombinants for the treatment of malignant glioma

    Matthias Gromeier;Sylvie Lachmann;Myrna R. Rosenfeld;Philip H. Gutin

  • Parthenogenetic stem cells in nonhuman primates

    Jose B. Cibelli;Kathleen A. Grant;Karen B. Chapman;Kerrianne Cunniff

  • Survival and Functional Status after Resection of Recurrent Glioblastoma Multiforme

    Fred G. Barker;Susan M. Chang;Philip H. Gutin;Mary K. Malec

  • Radiation therapy in the treatment of partially resected meningiomas.

    Nicholas M. Barbaro;Philip H. Gutin;Charles B. Wilson;Glenn E. Sheline

  • Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.

    Philip H. Gutin;Philip H. Gutin;Fabio M. Iwamoto;Kathryn Beal;Nimish A. Mohile

  • Diagnosis and treatment of atypical and anaplastic meningiomas: a review.

    Ashok Modha;Philip H. Gutin

  • Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

    F. M. Iwamoto;L. E. Abrey;K. Beal;P. H. Gutin

  • An integrated functional magnetic resonance imaging procedure for preoperative mapping of cortical areas associated with tactile, motor, language, and visual functions.

    Joy Hirsch;Maximilian I. Ruge;Maximilian I. Ruge;Karl H. S. Kim;Denise D. Correa;Denise D. Correa

  • Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.

    Christian Grommes;Christian Grommes;Alessandro Pastore;Nicolaos Palaskas;Sarah S Tang

  • Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

    Sandeep Kunwar;Michael D. Prados;Susan M. Chang;Mitchel S. Berger

  • Radiation Injury to the Nervous System

    P.H. Gutin;S.A. Leibel;G.E. Sheline;J.W. Ironside

  • Reoperation for Recurrent Glioblastoma and Anaplastic Astrocytoma

    Griffith R. Harsh;Victor A. Levin;Philip H. Gutin;Margaret Seager

Frequent Co-Authors

William M. Wara
William M. Wara Kaiser Permanente
David A. Larson
David A. Larson University of California, San Francisco
Theodore L. Phillips
Theodore L. Phillips University of California, San Francisco
Penny K. Sneed
Penny K. Sneed University of California, San Francisco
Michael D. Prados
Michael D. Prados University of California, San Francisco
Cameron Brennan
Cameron Brennan Memorial Sloan Kettering Cancer Center
Michael W. McDermott
Michael W. McDermott University of California, San Francisco
Richard L. Davis
Richard L. Davis University of California, San Francisco
Charles B. Wilson
Charles B. Wilson University of California, San Francisco
Kathleen R. Lamborn
Kathleen R. Lamborn University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals have a range of flexible pathways to jumpstart or advance their careers, even before or alongside traditional medical school. For example, nurses seeking to rise in leadership may consider the cheapest online DNP programs, which allow experienced RNs to pursue a doctorate in nursing practice at a lower cost.

If you’re looking for the quickest way to enter patient care, research what is the fastest way to become an LPN. These fast-track online Licensed Practical Nurse programs are designed for efficiency, helping you launch a nursing career in a matter of months.

Mental health is a growing field with strong demand. Nurses aiming to specialize should explore fast track mental health nursing programs. These online MSN options can accelerate your journey to become a Psychiatric-Mental Health Nurse Practitioner.

If you’re interested in the business side of healthcare, the cheapest MHA programs online make it affordable to earn a Master of Healthcare Administration and prepare for leadership roles.

Each of these online degrees offers practical, affordable routes to build skills and shape your career in the health sector.

Best Scientists Citing Philip H. Gutin

Trending Scientists